{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:41:01Z","timestamp":1791031261538,"version":"4.1.0"},"reference-count":74,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,1,1]]},"abstract":"<jats:p>Objective. To examine the impact of stimulant treatment during childhood and high school on risk for substance use, dependence, and abuse by young adulthood.<\/jats:p><jats:p>Methods. A total of 147 clinic-referred hyperactive children were followed approximately 13 years into adulthood (mean: 21 years old; range: 19\u201325). At adolescent (age 15) and adult follow-up, probands were interviewed about their use of various substances and duration of stimulant treatment.<\/jats:p><jats:p>Results. Duration of stimulant treatment was not significantly associated with frequency of any form of drug use by young adulthood. Stimulant-treated children had no greater risk of ever trying drugs by adolescence or any significantly greater frequency of drug use by young adulthood. Stimulant treatment in high school also did not influence drug use in adulthood except for greater use of cocaine. This difference was no longer significant after controlling for severity of attention-deficit\/hyperactivity disorder and conduct disorder in childhood, adolescence, and adulthood. Stimulant treatment in either childhood or high school was not associated with any greater risk for any formal Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised drug dependence or abuse disorders by adulthood. Treatment with stimulants did not increase the risk of ever having tried most illegal substances by adulthood except for cocaine. Subsequent analyses showed that this elevated risk was primarily mediated by severity of conduct disorder by young adulthood and not by stimulant treatment in childhood.<\/jats:p><jats:p>Conclusion. This study concurs with 11 previous studies in finding no compelling evidence that stimulant treatment of children with attention-deficit\/hyperactivity disorder leads to an increased risk for substance experimentation, use, dependence, or abuse by adulthood.<\/jats:p>","DOI":"10.1542\/peds.111.1.97","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"97-109","source":"Crossref","is-referenced-by-count":204,"title":["Does the Treatment of Attention-Deficit\/Hyperactivity Disorder With Stimulants Contribute to Drug Use\/Abuse? A 13-Year Prospective Study"],"prefix":"10.1542","volume":"111","author":[{"given":"Russell A.","family":"Barkley","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariellen","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Smallish","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2003,1,1]]},"reference":[{"key":"2021120821105443200_R1","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1987"},{"key":"2021120821105443200_R2","doi-asserted-by":"crossref","unstructured":"Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 2nd ed. New York, NY: Guilford; 1998","DOI":"10.1007\/978-1-4615-4881-2_13"},{"key":"2021120821105443200_R3","doi-asserted-by":"crossref","unstructured":"August GJ, Stewart MA, Holmes CS. A four-year follow-up of hyperactive boys with and without conduct disorder. Br J Psychiatry.1983;143:192\u2013198","DOI":"10.1192\/bjp.143.2.192"},{"key":"2021120821105443200_R4","doi-asserted-by":"crossref","unstructured":"Barkley RA, Fischer M, Edelbrock CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria, I: an 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry.1990;29:546\u2013557","DOI":"10.1097\/00004583-199007000-00007"},{"key":"2021120821105443200_R5","doi-asserted-by":"crossref","unstructured":"Claude D, Firestone P. The development of ADHD boys: a 12-year follow-up. Can J Behav Sci.1995;27:226\u2013249","DOI":"10.1037\/0008-400X.27.2.226"},{"key":"2021120821105443200_R6","doi-asserted-by":"crossref","unstructured":"Klein R, Mannuzza S. Long-term outcome of hyperactive children: a review. J Am Acad Child Adolesc Psychiatry.1991;30:383\u2013387","DOI":"10.1097\/00004583-199105000-00005"},{"key":"2021120821105443200_R7","doi-asserted-by":"crossref","unstructured":"Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit\/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol.2002;111:279\u2013289","DOI":"10.1037\/0021-843X.111.2.279"},{"key":"2021120821105443200_R8","doi-asserted-by":"crossref","unstructured":"Mannuzza S, Klein R, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry.1993;50:565\u2013576","DOI":"10.1001\/archpsyc.1993.01820190067007"},{"key":"2021120821105443200_R9","doi-asserted-by":"crossref","unstructured":"Mannuzza S, Klein R, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry.1998;155:493\u2013498","DOI":"10.1176\/ajp.155.4.493"},{"key":"2021120821105443200_R10","doi-asserted-by":"crossref","unstructured":"Mannuzza S, Klein RG, Bonagura N, Malloy P, Giampino H, Addalli KA. Hyperactive boys almost grown up: replication of psychiatric status. Arch Gen Psychiatry.1991;48:77\u201383","DOI":"10.1001\/archpsyc.1991.01810250079012"},{"key":"2021120821105443200_R11","unstructured":"Weiss G, Hechtman LT. Hyperactive Children Grown Up. 2nd ed. New York, NY: Guilford Press; 1993"},{"key":"2021120821105443200_R12","doi-asserted-by":"crossref","unstructured":"Fischer M, Barkley RA, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems. J Abnorm Child Psychol.2002;30:463\u2013475","DOI":"10.1023\/A:1019864813776"},{"key":"2021120821105443200_R13","unstructured":"DuPaul GJ, Barkley RA, Connor, DF. Stimulants. In: Barkley RA, ed. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York, NY: Guilford; 1998:510\u2013551"},{"key":"2021120821105443200_R14","doi-asserted-by":"crossref","unstructured":"Solanto MV, Arnsten AFT, Castellanos FX. Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. New York, NY: Oxford University Press; 2001","DOI":"10.1093\/oso\/9780195133714.001.0001"},{"key":"2021120821105443200_R15","doi-asserted-by":"crossref","unstructured":"The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder. Arch Gen Psychiatry.1999;56:1073\u20131086","DOI":"10.1001\/archpsyc.56.12.1073"},{"key":"2021120821105443200_R16","doi-asserted-by":"crossref","unstructured":"Findling RL, Short EJ, Manos MJ. Developmental aspects of psychostimulant treatment in children and adolescencets with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry.2001;40:1441\u20131447","DOI":"10.1097\/00004583-200112000-00015"},{"key":"2021120821105443200_R17","doi-asserted-by":"crossref","unstructured":"James RS, Sharp WS, Bastain TM, et al. Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD. J Am Acad Child Adolesc Psychiatry.2001;40:1268\u20131276","DOI":"10.1097\/00004583-200111000-00006"},{"key":"2021120821105443200_R18","doi-asserted-by":"crossref","unstructured":"Greenhill LL, Halperin JM, Abikoff A. Stimulant medications. J Am Acad Child Adolesc Psychiatry.1999;38:503\u2013512","DOI":"10.1097\/00004583-199905000-00011"},{"key":"2021120821105443200_R19","unstructured":"Rapport MD, Kelly KL. Psychostimulant effects on learning and cognitive functioning. In: Matson JL, ed. Handbook of Hyperactivity in Children. Boston, MA: Allyn & Bacon; 1993:97\u2013136"},{"key":"2021120821105443200_R20","doi-asserted-by":"crossref","unstructured":"Barkley RA, McMurray MB, Edelbrock CS, et al. The side effects of Ritalin: a systematic placebo controlled evaluation of two doses. Pediatrics.1990;86:184\u2013192","DOI":"10.1542\/peds.86.2.184"},{"key":"2021120821105443200_R21","doi-asserted-by":"crossref","unstructured":"Gillberg C, Melander H, von Knorring AL, et al. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. Arch Gen Psychiatry.1997;54:857\u2013864","DOI":"10.1001\/archpsyc.1997.01830210105014"},{"key":"2021120821105443200_R22","doi-asserted-by":"crossref","unstructured":"Safer DJ, Krager JM. A survey of medication treatment for hyperactive\/inattentive students. JAMA.1988;260:2256\u20132258","DOI":"10.1001\/jama.260.15.2256"},{"key":"2021120821105443200_R23","doi-asserted-by":"crossref","unstructured":"Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics.1996;98:1084\u20131088","DOI":"10.1542\/peds.98.6.1084"},{"key":"2021120821105443200_R24","doi-asserted-by":"crossref","unstructured":"Angold A, Erkanli A, Egger HL, Costello EJ. Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry.2000;39:975\u2013984","DOI":"10.1097\/00004583-200008000-00009"},{"key":"2021120821105443200_R25","doi-asserted-by":"crossref","unstructured":"Safer DJ, Krager M. Stimulant treatment in Maryland public schools. Pediatrics.2000;106:533\u2013539","DOI":"10.1542\/peds.106.3.533"},{"key":"2021120821105443200_R26","doi-asserted-by":"crossref","unstructured":"Jensen PS, Kettle L, Roper MT, et al. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. J Am Acad Child Adolesc Psychiatry.1999;38:797\u2013804","DOI":"10.1097\/00004583-199907000-00008"},{"key":"2021120821105443200_R27","doi-asserted-by":"crossref","unstructured":"Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA.2000;283:1025\u20131030","DOI":"10.1001\/jama.283.8.1025"},{"key":"2021120821105443200_R28","doi-asserted-by":"crossref","unstructured":"Lefever GB, Dawson KV, Morrow AL. The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. Am J Public Health.1999;89:1359\u20131364","DOI":"10.2105\/AJPH.89.9.1359"},{"key":"2021120821105443200_R29","unstructured":"Pear R. White house seeks to curb pills used to calm the young. New York Times.2000;March 20:A1, A16"},{"key":"2021120821105443200_R30","unstructured":"Hancock L. Mother\u2019s little helper. Newsweek.1996;March 18:51\u201356"},{"key":"2021120821105443200_R31","unstructured":"Pekkanen J. Making sense of Ritalin. Reader\u2019s Digest.2000;June:153\u2013158"},{"key":"2021120821105443200_R32","unstructured":"Rogers P. Drawing the line. People.2001;July 23:50\u201355"},{"key":"2021120821105443200_R33","doi-asserted-by":"crossref","unstructured":"Committee on Children with Disabilities and Committee on Drugs. Medication for children with attentional disorders. Pediatrics.1996;98:301\u2013304","DOI":"10.1542\/peds.98.2.301"},{"key":"2021120821105443200_R34","doi-asserted-by":"crossref","unstructured":"Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit\/hyperactivity disorder in children and adolescents. JAMA.1998;279:1100\u20131107","DOI":"10.1001\/jama.279.14.1100"},{"key":"2021120821105443200_R35","unstructured":"Breggin P. Talking Back to Ritalin. Monroe, ME: Common Courage Press; 1998"},{"key":"2021120821105443200_R36","unstructured":"Citizens Commission on Human Rights (CCHR). Ritalin: A Warning to Parents. Los Angeles, CA: Church of Scientology; 1987"},{"key":"2021120821105443200_R37","unstructured":"Greenhill L, Osmon B. Ritalin: Theory and Patient Management. New York, NY: Mary Ann Liebert; 1999"},{"key":"2021120821105443200_R38","doi-asserted-by":"crossref","unstructured":"Volkow ND, Ding Y, Fowler JS, et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry.1995;52:456\u2013463","DOI":"10.1001\/archpsyc.1995.03950180042006"},{"key":"2021120821105443200_R39","doi-asserted-by":"crossref","unstructured":"Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil.1998;31:533\u2013544","DOI":"10.1177\/002221949803100603"},{"key":"2021120821105443200_R40","unstructured":"Lambert NM. Stimulant treatment as a risk factor for nicotine use and substance abuse. In Jensen PS, Cooper JR, eds. Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder: An Evidence-Based Approach. New York, NY: American Medical Association Press; in press"},{"key":"2021120821105443200_R41","doi-asserted-by":"crossref","unstructured":"Strakowski SM, Szx KW. Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans. Biol Psychiatry.1998;44:1171\u20131177","DOI":"10.1016\/S0006-3223(97)00454-X"},{"key":"2021120821105443200_R42","doi-asserted-by":"crossref","unstructured":"Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev.1993;18:247\u2013291","DOI":"10.1016\/0165-0173(93)90013-P"},{"key":"2021120821105443200_R43","doi-asserted-by":"crossref","unstructured":"Horger BA, Giles MK, Schenk S. Pre-exposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacology (Berl).1992;107:271\u2013276","DOI":"10.1007\/BF02245147"},{"key":"2021120821105443200_R44","doi-asserted-by":"crossref","unstructured":"Lett BW. Repeated exposures intensify rather than diminish the rewarding effects of emphetamine, morphine, and cocaine. Psychopharmacology (Berl).1989;98:357\u2013362","DOI":"10.1007\/BF00451687"},{"key":"2021120821105443200_R45","doi-asserted-by":"crossref","unstructured":"Schenk S, partridge B. Sensitization and tolerance in psychostimulant self-administration. Pharmacol Biochem Behav.1997;57:543\u2013550","DOI":"10.1016\/S0091-3057(96)00447-9"},{"key":"2021120821105443200_R46","doi-asserted-by":"crossref","unstructured":"Chilcoat HD, Breslau N. Pathways from ADHD to early drug use. J Am Acad Child Adolesc Psychiatry.1999;38:1347\u20131354","DOI":"10.1097\/00004583-199911000-00008"},{"key":"2021120821105443200_R47","unstructured":"Loney J, Kramer JR, Salisbury H. Medicated versus unmedicated ADHD children: adult involvement with legal and illegal drugs. In: Jensen PS, Cooper JR, eds. Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder: An Evidence-Based Approach. New York, NY: American Medical Association Press; in press"},{"key":"2021120821105443200_R48","doi-asserted-by":"crossref","unstructured":"Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit\/hyperactivity disorder reduces risk for substance use disorder. Pediatrics.1999;104(2). Available at: www.pediatrics.org\/cgi\/content\/full\/104\/2\/e20","DOI":"10.1542\/peds.104.2.e20"},{"key":"2021120821105443200_R49","doi-asserted-by":"crossref","unstructured":"Burke JD, Loeber R, Lahey BB. Which aspects of ADHD are associated with tobacco use in early adolescence?J Child Psychol Psychiatry.2001;42:493\u2013502","DOI":"10.1111\/1469-7610.00743"},{"key":"2021120821105443200_R50","doi-asserted-by":"crossref","unstructured":"Milberger S, Biederman J, Faraone SV, Chen L, Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry.1997;36:37\u201344","DOI":"10.1097\/00004583-199701000-00015"},{"key":"2021120821105443200_R51","doi-asserted-by":"crossref","unstructured":"Paternite CE, Loney J, Salisbury H, Whaley MA. Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes. J Child Adolesc Psychopharmacol.1999;9:169\u2013184","DOI":"10.1089\/cap.1999.9.169"},{"key":"2021120821105443200_R52","doi-asserted-by":"crossref","unstructured":"Blouin AGA, Bornstein R, Trite R. Teenage alcohol use among hyperactive children: a 5-year follow-up study. J Pediatr Psychol.1978;3:188\u2013194","DOI":"10.1093\/jpepsy\/3.4.188"},{"key":"2021120821105443200_R53","doi-asserted-by":"crossref","unstructured":"Beck L, Langford WS, Mackay M, Sum G. Childhood chemotherapy and later drug abuse and growth curve: a follow-up study of 30 adolescents. Am J Psychiatry.1975;132:436\u2013438","DOI":"10.1176\/ajp.132.4.436"},{"key":"2021120821105443200_R54","unstructured":"Henker B, Whalen C, Bugental DB, Barker C. Licit and illicit substance use patterns in stimulant-treated children and their peers. In: Gadow K, Loney J, eds. Psychosocial Aspects of Drug Treatment for Hyperactivity. Boulder, CO: Westview Press; 1981"},{"key":"2021120821105443200_R55","unstructured":"Feldman S, Denhoff, E, Denhoff J. The attention disorders and related syndromes: outcome in adolescence and young adult life. In: Stern L, Denhoff E, eds. Minimal Brain Dysfunction: A Developmental Approach. New York, NY: Masson Publishing; 1979"},{"key":"2021120821105443200_R56","doi-asserted-by":"crossref","unstructured":"Mick E, Biederman J, Faraone SV. Comment on Lambert and Hartsough (1998). J Learn Dis.2000;33:314","DOI":"10.1177\/002221940003300401"},{"key":"2021120821105443200_R57","doi-asserted-by":"crossref","unstructured":"Brook JS, Whiteman M, Finch SJ, Cohen P. Young adult drug use and delinquency: childhood antecedents and adolescent mediators. J Am Acad Child Adolesc Psychiatry.1996;35:1584\u20131592","DOI":"10.1097\/00004583-199612000-00009"},{"key":"2021120821105443200_R58","doi-asserted-by":"crossref","unstructured":"Molina BSG, Smith BH, Pelham WE. Interactive effects of attention deficit hyperactivity disorder and conduct disorder on early adolescent substance use. Psychol Addict Behav.1999;13:348\u2013358","DOI":"10.1037\/0893-164X.13.4.348"},{"key":"2021120821105443200_R59","doi-asserted-by":"crossref","unstructured":"White HR, Xie M, Thompson W, Loeber R, Southamer-Loeber M. Psychopathology as a predictor of adolescent drug use trajectories. Psychol Addict Behav.2001;15:210\u2013218","DOI":"10.1037\/0893-164X.15.3.210"},{"key":"2021120821105443200_R60","doi-asserted-by":"crossref","unstructured":"Goyette CH, Conners CK, Ulrich RF. Normative data for Revised Conners Parent and Teacher Rating Scales. J Abnorm Child Psychol.1978;6:221\u2013236","DOI":"10.1007\/BF00919127"},{"key":"2021120821105443200_R61","unstructured":"Barkley RA. Hyperactive Children: A Handbook for Diagnosis and Treatment. New York, NY: Guilford; 1981"},{"key":"2021120821105443200_R62","doi-asserted-by":"crossref","unstructured":"Edelbrock CS, Costello A. Convergence between statistically derived behavior problem syndromes and child psychiatric diagnoses. J Abnorm Child Psychol.1988;16:219\u2013231","DOI":"10.1007\/BF00913597"},{"key":"2021120821105443200_R63","unstructured":"Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York, NY: Guilford; 1990"},{"key":"2021120821105443200_R64","unstructured":"Werry J, Sprague R. Hyperactivity. In: Costello CG, ed. Symptoms of Psychopathology. New York, NY: Wiley; 1970:397\u2013417"},{"key":"2021120821105443200_R65","doi-asserted-by":"crossref","unstructured":"Routh DK, Schroeder CS, O\u2019Tuama L. The development of activity level in children. Dev Psychol.1974;10:163\u2013168","DOI":"10.1037\/h0035993"},{"key":"2021120821105443200_R66","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, Revised. Washington, DC: American Psychiatric Association; 1987"},{"key":"2021120821105443200_R67","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell D, Biederman J, Jones J, et al. Informativeness of child and parent reports on substance use disorders in a sample of ADHD probands, control probands, and their siblings. J Am Acad Child Adolesc Psychiatry.1998;37:752\u2013758","DOI":"10.1097\/00004583-199807000-00015"},{"key":"2021120821105443200_R68","unstructured":"Mannuzza S, Gittelman R. Informant variance in the diagnostic assessment of hyperactive children as young adults. In: Barrett JE, Rose RM, eds. Mental Disorders in the Community. New York, NY: Guilford; 1986:243\u2013254"},{"key":"2021120821105443200_R69","unstructured":"Spitzer RL, Williams J, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). New York, NY: Biometric Research Department, New York State Psychiatric Institute; 1989"},{"key":"2021120821105443200_R70","doi-asserted-by":"crossref","unstructured":"Fergusson DM, Swain-Campbell NR, Horwood LJ. Deviant peer affiliations, crime and substance use: a fixed effects regression analysis. J Abnorm Child Psychol.2002;30:419\u2013430","DOI":"10.1023\/A:1015774125952"},{"key":"2021120821105443200_R71","doi-asserted-by":"crossref","unstructured":"Whalen CK, Jamer LD, Henker B, Delfino RJ, Lozano JM. The ADHD spectrum and everyday life: experience sampling of adolescent moods, activities, smoking, and drinking. Child Dev.2002;73:209\u2013227","DOI":"10.1111\/1467-8624.00401"},{"key":"2021120821105443200_R72","doi-asserted-by":"crossref","unstructured":"Kuperman S, Schlosser SS, Kramer JR, et al. Developmental sequence from disruptive behavior diagnosis to adolescent alcohol dependence. Am J Psychiatry.2001;158:2022\u20132026","DOI":"10.1176\/appi.ajp.158.12.2022"},{"key":"2021120821105443200_R73","doi-asserted-by":"crossref","unstructured":"Loeber R, Burke JD, Lahey BB, Winters A, Zera M. Oppositional defiant and conduct disorder: a review of the past 10 years, part I. J Am Acad Child Adolesc Psychiatry.2000;39:1\u201317","DOI":"10.1097\/00004583-200012000-00007"},{"key":"2021120821105443200_R74","unstructured":"Barkley RA, Fischer M, Smallish L, Fletcher KR. Young adult follow-up of hyperactive children: antisocial activity and drug use. J Child Psychol Psychiatry. In press"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/1\/97\/1006215\/pe0103000097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/1\/97\/1006215\/pe0103000097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T08:13:57Z","timestamp":1734509637000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/111\/1\/97\/28549\/Does-the-Treatment-of-Attention-Deficit"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,1]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,1,1]]},"published-print":{"date-parts":[[2003,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.111.1.97","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,1]]}}}